Nctid:
NCT00001349
Payload:
{"FullStudy"=>{"Rank"=>474303, "Study"=>{"DerivedSection"=>{"MiscInfoModule"=>{"VersionHolder"=>"December 08, 2023"}}, "ProtocolSection"=>{"DesignModule"=>{"BioSpec"=>{"BioSpecRetention"=>"Samples With DNA", "BioSpecDescription"=>"Leukocytes, platelets and plasma will be collected. Since this protocol only allows for apheresis to be performed on participants enrolled on another LPD protocol, any biological samples collected will be covered by the other, individual protocol on which the participant is enrolled."}, "StudyType"=>"Observational", "DesignInfo"=>{"DesignTimePerspectiveList"=>{"DesignTimePerspective"=>["Other"]}, "DesignObservationalModelList"=>{"DesignObservationalModel"=>["Other"]}}, "EnrollmentInfo"=>{"EnrollmentType"=>"Actual", "EnrollmentCount"=>"205"}}, "StatusModule"=>{"WhyStopped"=>"Closed at the request of the IRBO", "OverallStatus"=>"Terminated", "StartDateStruct"=>{"StartDate"=>"March 23, 1993", "StartDateType"=>"Actual"}, "ExpandedAccessInfo"=>{"HasExpandedAccess"=>"No"}, "StatusVerifiedDate"=>"November 2021", "CompletionDateStruct"=>{"CompletionDate"=>"November 9, 2021", "CompletionDateType"=>"Actual"}, "LastUpdateSubmitDate"=>"November 9, 2021", "StudyFirstSubmitDate"=>"November 3, 1999", "StudyFirstSubmitQCDate"=>"November 3, 1999", "LastUpdatePostDateStruct"=>{"LastUpdatePostDate"=>"November 10, 2021", "LastUpdatePostDateType"=>"Actual"}, "StudyFirstPostDateStruct"=>{"StudyFirstPostDate"=>"November 4, 1999", "StudyFirstPostDateType"=>"Estimate"}, "PrimaryCompletionDateStruct"=>{"PrimaryCompletionDate"=>"November 9, 2021", "PrimaryCompletionDateType"=>"Actual"}}, "OutcomesModule"=>{"PrimaryOutcomeList"=>{"PrimaryOutcome"=>[{"PrimaryOutcomeMeasure"=>"To obtain leukocytes,platelets, and plasma from subjects already enrolled on other NIAID/LPD protocols.", "PrimaryOutcomeTimeFrame"=>"Ongoing as this is a method to collect cells from subjects enrolled on other LPD protocols", "PrimaryOutcomeDescription"=>"Leukocytes, platelets, and plasma will be collected."}]}}, "OversightModule"=>{}, "ConditionsModule"=>{"KeywordList"=>{"Keyword"=>["Plasmapheresis", "Lymphocytes", "Eosinophils", "Neutrophils"]}, "ConditionList"=>{"Condition"=>["Leukopheresis", "Plasmapheresis"]}}, "ReferencesModule"=>{"ReferenceList"=>{"Reference"=>[{"ReferencePMID"=>"25255226", "ReferenceType"=>"background", "ReferenceCitation"=>"Boyd A, Ribeiro JM, Nutman TB. Human CD117 (cKit)+ innate lymphoid cells have a discrete transcriptional profile at homeostasis and are expanded during filarial infection. PLoS One. 2014 Sep 25;9(9):e108649. doi: 10.1371/journal.pone.0108649. eCollection 2014."}, {"ReferencePMID"=>"25667413", "ReferenceType"=>"background", "ReferenceCitation"=>"Chatterjee S, Clark CE, Lugli E, Roederer M, Nutman TB. Filarial infection modulates the immune response to Mycobacterium tuberculosis through expansion of CD4+ IL-4 memory T cells. J Immunol. 2015 Mar 15;194(6):2706-14. doi: 10.4049/jimmunol.1402718. Epub 2015 Feb 9."}, {"ReferencePMID"=>"25404363", "ReferenceType"=>"background", "ReferenceCitation"=>"Santiago Hda C, Ribeiro-Gomes FL, Bennuru S, Nutman TB. Helminth infection alters IgE responses to allergens structurally related to parasite proteins. J Immunol. 2015 Jan 1;194(1):93-100. doi: 10.4049/jimmunol.1401638. Epub 2014 Nov 17."}]}, "SeeAlsoLinkList"=>{"SeeAlsoLink"=>[{"SeeAlsoLinkURL"=>"https://clinicalstudies.info.nih.gov/cgi/detail.cgi?A_1993-I-0057.html", "SeeAlsoLinkLabel"=>"NIH Clinical Center Detailed Web Page"}]}}, "DescriptionModule"=>{"BriefSummary"=>"This study will collect blood plasma and white blood cells for laboratory research using a procedure called apheresis. Apheresis is a method of collecting larger quantities of certain blood components than can safely be collected through a simple blood draw.\n\nPatients 7 years of age and older with a parasitic infection or condition associated with a parasitic infection (i.e., elevated levels of IgE antibodies or of a type of white cell called eosinophils) who are currently enrolled in a NIH clinical research protocol may be eligible for this study. Relatives of patients and normal healthy volunteers will also be enrolled. Candidates will have a medical history, physical examination and blood tests. Individuals weighing less than 25 kilograms (55 pounds) may not participate.\n\nParticipants will undergo one of the following two apheresis procedures:\n\nAutomated pheresis Whole blood is drawn through a needle placed in an arm vein and circulated through a cell separator machine. The plasma (liquid part of the blood) and white cells are extracted, and the red cells are re-infused into the donor through a needle in the other arm. The procedure takes 1 to 2 hours.\nManual pheresis Whole blood is drawn through a needle placed in an arm vein and circulated through the cell separator machine. The red blood cells are separated from the rest of the blood and returned to the donor through the same needle. Usually only one needle stick is required and the procedure takes from 30 to 45 minutes. This method is used only in individuals who weigh less than 35 kg (77 pounds).", "DetailedDescription"=>"In order to carry out in vitro research procedures on the plasma or leukocyte components of blood, it is often necessary to obtain larger quantities of plasma and/or leukocytes, than can be safely obtained by simple phlebotomy. These components can be easily and safely obtained using apheresis procedures in the Clinical Center Apheresis Unit. This protocol is specifically designed to conform to the requirements of the Apheresis Unit for donors to have apheresis procedures (>7 years of age and greater than or equal to 25kg). Donors must first be admitted to another approved clinical research protocol of the LPD, NIAID before they may have the apheresis procedures described in this protocol. The investigational nature of the studies in which the samples will be used, as well as the risks and benefits of the donation process will be explained to all donors, and a signed informed consent document will be obtained."}, "EligibilityModule"=>{"Gender"=>"All", "MinimumAge"=>"8 years", "StdAgeList"=>{"StdAge"=>["Child", "Adult", "Older Adult"]}, "SamplingMethod"=>"Non-Probability Sample", "StudyPopulation"=>"Any subject enrolled on an existing !RB-approved LPD protocol may be asked to participate and thereby undergo apheresis.", "HealthyVolunteers"=>"No", "EligibilityCriteria"=>"INCLUSION CRITERIA:\nEnrolled on another LPD protocol.\nWeight greater than or equal to 25 kg\nWillingness to participate\n\nEXCLUSION CRITERIA:\n\nAge less than 7 years\nWeight less than 25 kg\nCardiovascular instability\nHct less than 30\nInadequate venous access\nPTT or PT greater than 1.5 normal\nPregnancy\nWomen who are actively breastfeeding\nOther condition which the attending physician or Apheresis Unit staff considers a contraindication to the procedure\n\nFor Hetastarch procedure\n\nHypertension\nEvidence of fluid retention"}, "IdentificationModule"=>{"NCTId"=>"NCT00001349", "BriefTitle"=>"Apheresis to Obtain Plasma or White Blood Cells for Laboratory Studies", "Organization"=>{"OrgClass"=>"NIH", "OrgFullName"=>"National Institutes of Health Clinical Center (CC)"}, "OfficialTitle"=>"Apheresis Procedures to Obtain Plasma or Leukocytes for In Vitro Studies", "OrgStudyIdInfo"=>{"OrgStudyId"=>"930057"}, "SecondaryIdInfoList"=>{"SecondaryIdInfo"=>[{"SecondaryId"=>"93-I-0057"}]}}, "ArmsInterventionsModule"=>{"ArmGroupList"=>{"ArmGroup"=>[{"ArmGroupLabel"=>"1", "ArmGroupDescription"=>"Donors first admitted to another approved clinical research protocol of the NIAID before having the apheresis procedures described in this protocol."}]}}, "ContactsLocationsModule"=>{"LocationList"=>{"Location"=>[{"LocationZip"=>"20892", "LocationCity"=>"Bethesda", "LocationState"=>"Maryland", "LocationCountry"=>"United States", "LocationFacility"=>"National Institutes of Health Clinical Center, 9000 Rockville Pike"}]}, "OverallOfficialList"=>{"OverallOfficial"=>[{"OverallOfficialName"=>"Thomas B Nutman, M.D.", "OverallOfficialRole"=>"Principal Investigator", "OverallOfficialAffiliation"=>"National Institute of Allergy and Infectious Diseases (NIAID)"}]}}, "SponsorCollaboratorsModule"=>{"LeadSponsor"=>{"LeadSponsorName"=>"National Institute of Allergy and Infectious Diseases (NIAID)", "LeadSponsorClass"=>"NIH"}, "ResponsibleParty"=>{"ResponsiblePartyType"=>"Sponsor"}}}}}}
